| __timestamp | Alkermes plc | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 347523000 |
| Thursday, January 1, 2015 | 4019000 | 479514000 |
| Friday, January 1, 2016 | 2301000 | 581861000 |
| Sunday, January 1, 2017 | 7232000 | 1326361000 |
| Monday, January 1, 2018 | 68895000 | 1197957000 |
| Tuesday, January 1, 2019 | 52816000 | 1154111000 |
| Wednesday, January 1, 2020 | 1946000 | 2215942000 |
| Friday, January 1, 2021 | 1020000 | 1458179000 |
| Saturday, January 1, 2022 | 393842000 | 1585936000 |
| Sunday, January 1, 2023 | 270806000 | 1627594000 |
| Monday, January 1, 2024 | 245326000 | 2606848000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Incyte Corporation and Alkermes plc have demonstrated contrasting approaches to R&D spending. From 2014 to 2023, Incyte Corporation consistently outpaced Alkermes in R&D investment, with expenditures peaking at approximately $1.6 billion in 2023, a staggering 370% increase from 2014. In contrast, Alkermes plc's R&D spending showed more volatility, with a notable peak in 2022 at around $394 million, before slightly declining in 2023. This disparity highlights Incyte's robust commitment to innovation, potentially driving its competitive edge in the biotech sector. As the industry evolves, these strategic financial decisions could significantly impact each company's future market position and product pipeline.
Eli Lilly and Company or Alkermes plc: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for BeiGene, Ltd. and Alkermes plc
Research and Development Investment: Incyte Corporation vs Intra-Cellular Therapies, Inc.
Cost of Revenue Comparison: Incyte Corporation vs Alkermes plc
Analyzing R&D Budgets: Incyte Corporation vs Halozyme Therapeutics, Inc.
Research and Development Investment: Incyte Corporation vs Xenon Pharmaceuticals Inc.
R&D Insights: How Incyte Corporation and Wave Life Sciences Ltd. Allocate Funds
R&D Insights: How Incyte Corporation and Dynavax Technologies Corporation Allocate Funds
Research and Development Expenses Breakdown: Incyte Corporation vs Taro Pharmaceutical Industries Ltd.
Research and Development Investment: Summit Therapeutics Inc. vs Alkermes plc
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and Alkermes plc
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending